Glen Harbor Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $2.84M | Sell |
10,234
-136
| -1% | -$37.7K | 0.06% | 270 |
|
|
2019
Q2 | $3.25M | Sell |
10,370
-8,568
| -45% | -$2.68M | 0.07% | 252 |
|
|
2019
Q1 | $7.78M | Buy |
18,938
+12,750
| +206% | +$5.24M | 0.17% | 125 |
|
|
2018
Q4 | $2.31M | Buy |
6,188
+1,666
| +37% | +$622K | 0.06% | 291 |
|
|
2018
Q3 | $1.83M | Buy |
4,522
+1,020
| +29% | +$412K | 0.04% | 351 |
|
|
2018
Q2 | $1.21M | Buy |
3,502
+68
| +2% | +$23.5K | 0.03% | 393 |
|
|
2018
Q1 | $1.18M | Sell |
3,434
-578
| -14% | -$199K | 0.03% | 383 |
|
|
2017
Q4 | $1.51M | Buy |
4,012
+1,870
| +87% | +$703K | 0.03% | 353 |
|
|
2017
Q3 | $958K | Sell |
2,142
-102
| -5% | -$45.6K | 0.02% | 419 |
|
|
2017
Q2 | $1.1M | Sell |
2,244
-238
| -10% | -$117K | 0.03% | 404 |
|
|
2017
Q1 | $962K | Sell |
2,482
-34
| -1% | -$13.2K | 0.02% | 412 |
|
|
2016
Q4 | $923K | Buy |
+2,516
| New | +$923K | 0.03% | 385 |
|